glp-1 black box warning Your guide to side effects Thyroid Cancer: A Black-Box Warning

Efficacy and safety of adding once-weekly dulaglutide to basal insulin for inadequately controlled type 2 diabetes in Chinese patients (AWARD-CHN3): A randomized, double-blind, placebo-controlled, phase III trial

But the details matter more than the marketing

As our shakes are designed for anyone who wants to boost their nutrient intake all year round, we would certainly recommend you continue taking our shakes even when you stop GLP-1

You are usually kept on each dose for four weeks before moving up to the next dose

503A patient-specific compounding continues under narrower exceptions

J Clin Endocrinol Metab (2020) 105:295063